Merck & Company Inc.MRK
Close of Friday, October 23, 2026 · Merck & Company Inc. is trading above its Pivot, OnlyAlpha's long-term trend line.
Price
$145.27
vs its Pivot
+15.4%
OnlyAlpha Score
59
Trend
Above its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -1.8% | +40.9% | +70.7% | +16.0% | +16.7% |
Dividend: $3.40 a share over the last 12 months, a 2.34% yield at today's price.
Who runs and owns it
In these funds
Big investors that own it (latest 13F)
| OrbiMed | 1.6% of holdings |
| Norway (Norges Bank) | 0.5% of holdings |
| New York State Common | 0.5% of holdings |
| CalPERS | 0.4% of holdings |
| Canada Pension Plan | 0.3% of holdings |
| Temasek | 0.3% of holdings |
Suppliers, customers and partners
Partners and deals
| Gilead Sciences | oncology collaboration |
| Moderna | intismeran (mRNA-4157) |
| AstraZeneca | Lynparza |
| Eisai | Lenvima |
| Bayer AG | Adempas |
From the companies' own annual reports filed with the SEC.
Healthcare · Pharma
Get MRK in your free daily emailAfter every close: whether MRK is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track MRK free → Full Stock check
Track MRK free → Full Stock check